Antitumor and antiviral activity of pentacyclic triterpenes

Mini-Reviews in Organic Chemistry

Volumn 11, Issue 3, 2014, Pages 262-268

  Paduch, Roman ^a   Kandefer Szerszeń, Martyna ^a  

^a MARIA CURIE SK ODOWSKA UNIVERSITY   (Poland)

Author keywords

Antitumor; Antiviral; Triterpenes

Indexed keywords

CARBOXYLIC ACIDS;

ANTI-TUMORS; ANTITUMOUR ACTIVITY; ANTIVIRAL ACTIVITIES; ANTIVIRALS; MEDICINAL PLANTS; PENTACYCLIC TRITERPENES; PENTACYCLIC TRITERPENOIDS; PHARMACOLOGICAL PROPERTIES; TRITERPENES; TRITERPENOIDS;

CELL CULTURE;

EID: 84911388077     PISSN: 1570193X     EISSN: 18756298     Source Type: Journal    
DOI: 10.2174/1570193X1103140915105240     Document Type: Article

References (67)

1. Abuznait, A.H.; Qosa, H.; O’Connell, N.D.; Akbarian-Tefaghi, J.; Sylvester, P.W.; El Sayed, K.A.; Kaddoumi, A. Induction of expression and functional activity of P-glycoprotein efflux transporter by bioactive plant natural products. Food Chem. Toxicol., 2001, 49, 2765-2772.
2. Zheng, Y.; Zhou, F.; Wu, X.; Wen, X.; Li, Y.; Yan, B.; Zhang, J.; Hao, G.; Ye, W.; Wang, G. 23-Hydroxybetulinic acid from Pulsatilla chinensis (Bunge) Regel synergizes the antitumor activities of doxorubicin in vitro and in vivo. J. Ethnopharmacol., 2010, 128, 615-622.
3. Shanmugam, M.K.; Nguyen, An.H.; Kumar, A.P.; Tan, B.K.H.; Sethi, G. Targeted inhibition of tumor proliferation, survival, and metastasis by pentacyclic terpenoids: Potential role in prevention and therapy of cancer. Cancer Lett., 2012, 320, 158-170.
4. Hill, R.A.; Connolly J.D. Triterpenoids. Nat. Prod. Rep., 2011, 28, 1087-1117.
5. Kavitha, C.V.; Agarwal, Ch.; Agarwal, R.; Deep, G. Asiatic acid inhibits pro-angiogenic effects of VEGF and human gliomas in endothelial cell culture models. PloS One, 2011, 6, e22745.
6. Cho, C.W.; Choi, D.S.; Cardone, M.H.; Kim, C.W.; Sinskey, A.J.; Rha, C. Glioblastoma cell death induced by Asiatic acid. Cell Biol. Toxicol., 2006, 22, 393-408.
7. Tang, X.-L.; Yang, X.-Y.; Jung, H.-J.; Kim, S.-Y.; Jung, S.-Y.; Choi, D.-Y., Park, W.-C.; Park, H. Asiatic acid induces colon cancer cell growth inhibition and apoptosis through mitochondrial death cascade. Biol. Pharm. Bull., 2009, 32, 1399-1405.
8. Liby, K.; Honda, T.; Williams, Ch.R.; Risingsong, R.; Royce, D.B.; Suh, N.; Dinkova-Kostova, A.T.; Stephenson, K.K.; Talalay, P.; Sundararajan, Ch.; Gribble, G.W.; Sporn, M.B. Novel semisynthetic analogues of betulinic acid with diverse cytoprotective, antiproliferative, and proapoptotic activities. Mol. Cancer Ther., 2007, 6, 2113-2119.
9. Bache, M.; Zschornak, M.P.; Passin, S.; Kessler, J.; Wichmann, H.; Kappler, M.; Paschke, R.; Kaluderović, G.N.; Kommera, H.; Taubert, H.; Vordemark, D. Increased betulinic acid induced cytotoxicity and radiosensitivity in glioma cells under hypoxic conditions. Radiat. Oncol., 2011, 6, 111.
10. Santos, R.C.; Salvador, J.A.R.; Cortés, R.; Pachón, G.; Marín, S.; Cascante, M. New betulinic acid derivatives induce potent and selective antiproliferative activity through cell cycle arrest at the S phase and caspase dependent apoptosis in human cancer cells. Biochimie, 2011, 93, 1065-1075.
11. Suresh, Ch.; Zhao, H.; Gumbs, A.; Chetty, C.S.; Bose, H.S. New ionic derivatives of betulinic acid as highly potent anti-cancer agents. Bioorg. Med. Chem. Lett., 2012, 22, 1734-1738.
12. Mertens-Talcott, S.U.; Noratto, G.D.; Li, X.; Angel-Morales, G.; Bertoldi, M.C.; Safe, S. Betulinic acid decreases ER-negative breast cancer cell growth in vitro and in vivo: Role of Sp transcription factors and microRNA-27a:ZBTB10. Mol. Carcinog., 2013, 52(8), 591-602.
13. Chintharlapalli, S.; Papineni, S.; Lei, P.; Pathi, S.; Safe, S. Betulinic acid inhibits colon cancer cell and tumor growth and induces proteasome-dependent and -independent downregulation of specificity proteins (Sp) transcription factors. Br Med Cent Cancer, 2011, 11, 371.
14. Mullauer, F.B.; van Bloois, L.; Daalhuisen, J.B.; Ten Brink, M.S.; Storm, G.; Medema, J.P.; Schiffelers, R.M.; Kessler, J.H. Betulinic acid delivered in liposomes reduces growth of human lung and colon cancers in mice without causing systemic toxicity. Anti- Cancer Drugs, 2011, 22, 223-233.
15. Moussaieff, A.; Mechoulam, R. Boswellia resin: from religious ceremonies to medical uses; a review of in-vitro, in-vivo and clinical trials. J. Pharm. Pharmacol., 2009, 61, 1281-1293.
16. Shen, Y.; Takahashi, M.; Byun, H.M.; Link, A.; Sharma, N.; Balaguer, F.; Leung, H.C.; Boland, R.; Goel, A. Boswellic acid induces epigenetic alterations by modulating DNA methylation in colorectal cancer cells. Cancer Biol. Ther., 2012, 13, 542-552.
17. Pang, X.; Yi, Z.; Zhang, X.; Sung, B.; Qu, W.; Lian, X.; Aggarwal, B.B.; Liu, M. Acetyl-11-keto-beta-boswellic acid inhibits prostate tumor growth by suppressing vascular endothelial growth factor receptor 2-mediated angiogenesis. Cancer Res., 2009, 69, 5893-5900.
18. Shetty, A.V.; Thirugnanam, S.; Dakshinamootrthy, G.; Samykutty, A.; Zheng, G.; Chen, A.; Bosland, M.C.; Kajdacsy-Balla, A.; Gnanasekar, M. 18α-glycyrrhetinic acid targets prostate cancer cells by down-regulating inflammation-related genes. Int. J. Oncol., 2011, 39, 635-640.
19. Cherng, J.M.; Tsai, K.D.; Yu, Y.W.; Lin, J.C. Molecular mechanisms underlaying chemopreventive activities of glycyrrhizic acid against UVB-radiation-induced carcinogenesis in SKH-1 hairless mouse epidermis. Radiat. Res., 2011, 176, 177-186.
20. Chaturvedi, P.K.; Bhui, K.; Shukla, Y. Lupeol: Connotations for chemoprevention. Cancer Lett., 2008, 263, 1-13.
21. Siddique, H.R.; Mishra, S.K.; Karnes, R.J.; Saleem, M. Lupeol, a novel androgen receptor inhibitor: implications in prostate cancer therapy. Clin. Cancer Res., 2011, 17, 5379-5391.
22. Saleem, M. Lupeol, a novel anti-inflammatory and anti-cancer dietary triterpene. Cancer Lett., 2009, 285, 109-115.
23. Siddique, H.R.; Saleem, M. Beneficial health effects of lupeol triterpene: A review of preclinical studies. Life Sci., 2011, 88, 285-293.
24. Vachalkova, A.; Ovesna, Z.; Horvathova, K.; Tothova, D. Pentacyclic triterpenoic acids: new chemoprotective compounds. Neoplasma, 2004, 51, 327-333.
25. Wójciak-Kosior, M.; Paduch R.; Matysik-Woźniak A.; Niedziela P.; Donica H. The effect of oleanolic and ursolic acids on human skin fibroblast cells. Folia Histochem. Cytobiol., 2011, 49, 664-669.
26. Zheng, Q.Y.; Jin, F.S.; Yao, C.; Zhang, G.H.; Ai, X. Ursolic acidinduced AMP-activated protein kinase (AMPK) activation contributes to growth inhibition and apoptosis in human bladder cancer T24 cells. Biochem. Biophys. Res. Commun., 2012, 419, 741-747.
27. Huang, Ch.-Y.; Lin, Ch.-Y.; Tsai, Ch.-W.; Yin, M.-C. Inhibition of cell proliferation, invasion and migration by ursolic acid in human lung cancer cell lines. Toxicol. In Vitro, 2011, 25, 1274-1280.
28. Koh, S.J.; Tak, J.K.; Kim, S.T.; Nam, W.S.; Kim, S.Y.; Park, K.M.; Park, J.W. Sensitization of ionizing radiation-induced apoptosis by ursolic acid. Free Radic. Res., 2012, 46, 339-345.
29. Lúcio, K.A.; Rocha, G.G.; Monção-Ribeiro, L.C.; Fernandes, J.; Takiya, Ch. M.; Gattass, C.R. Oleanolic acid initiates apoptosis in non-small cell lung cancer cell lines and reduces metastasis of a B16F10 melanoma model in vitro. PloS One, 2011, 6, e28596.
30. Fujioka, T.; Kashiwada, Y.; Kilkuskie, R.E.; Cosentino, L.M.; Ballas, L.M.; Jiang, J.B.; Janzen, W.P.; Chen, I.S.; Lee, K.H. Anti- AIDS agents, 11. Betulinic acid and platanic acid as anti-HIV principles from Syzigium claviflorum, and the anti-HIV activity of structurally related triterpenoids. J. Nat. Prod., 1994, 57, 243-247.
31. Yu, D.; Wild, C.T.; Martin, D.E.; Morris-Natschke, S.L.; Chen, C.H.; Allaway, G.P.; Lee, K.H. The discovery of a class of novel HIV-1 maturation inhibitors and their potential in the therapy of HIV. Expert Opin. Investig. Drugs, 2005, 14, 681-693.
32. Kashiwada, Y.; Hashimoto, F.; Cosentino, L.M.; Chen, C.H.; Garrett, P.A.; Lee, K.H. Betulinic acid and dihydrobetulinic acid derivatives as potent anti-HIV agents. J. Med. Chem., 1996, 39, 1016-1017.
33. Qian, K.; Nitz, T.J.; Yu, D.; Allaway, G.P.; Morris-Natschke, S.L.; Lee K.H. In: Natural Product Chemistry for Drug Discovery. Buss AD, Butler M, editors. RSC Publishing; Cambridge, UK, 2010, Chapter 13, pp. 374-391.
34. Soler, F.; Poujade, C.; Evers, M.; Carry, J.C.; Hénin, Y.; Bousseau, A.; Huet, T.; Pauwels, R.; De Clercq, E.; Mayaux, J.F.; Le Pecq, J.B.; Dereu, N. Betulinic acid derivatives: a new class of specific inhibitors of human immunodeficiency virus type 1 entry. J. Med. Chem., 1996, 39, 1069-1083.
35. Qian, K.; Morris-Natschke, S.L.; Lee, K.H. HIV entry inhibitors and their potential in HIV therapy. Med. Res. Rev., 2009, 29, 369-393.
36. Qian, K; Yu, D.; Chen, C.H.; Huang, L.; Morris-Natschke, S.L.; Nitz, T.J.; Salzwedel, K.; Reddick, M.; Allaway, G.P.; Lee, K.H. Anti-AIDS agents. 78. Design, synthesis, metabolic stability assessment, and antiviral evaluation of novel betulinic acid derivatives as potent anti-human immunodeficiency virus (HIV) agents. J. Med. Chem., 2006, 49, 5462-5469.
37. Kanamoto, T.; Kashiwada, Y.; Kanbara, K.; Gotoh, K.; Yoshimori, M.; Goto, T.; Sano, K.; Nakashima, H. Anti-human immunodeficiency virus activity of YK-FH312 (a betulinic acid derivative), a novel compound blocking viral maturation. Antimicrob. Agents Chemother., 2001, 45, 1225-1230.
38. Yu, D.; Sakurai, Y.; Chen, C.H.; Chang, F.R.; Huang, L.; Kashiwada, Y.; Lee, K.H. Anti-AIDS agents 69. Moronic acid and other triterpene derivatives as novel potent anti-HIV agents. J. Nat. Prod., 2009, 72, 1917-26.
39. Pohjala, L.; Alakurtti, S.; Ahola, T.; Yli-Kauhaluoma, J.; Tammela, P. Betulin-derived compounds as inhibitors of alphavirus replication. Antimicrob. Agents Chemother., 2001, 45, 1225-30.
40. Pavlova, N.I.; Savinova, O.V.; Nikolaeva, S.N.; Boreko, E.I.; Flekhter O.B. Antiviral activity of betulin, betulinic and betulonic acids against some enveloped and non-enveloped viruses. Fitoterapia, 2003, 74, 489-492.
41. Flekhter, O.B.; Karachurina, L.T.; Nigmatullina, L.R.; Sapozhnikova, T.A.; Baltina L.A.; Zarudii, F.S.; Galin, F.Z.; Spirikhin, L.V.; Tolstikov, G.A.; Plyasunova, O.A.; Pokrovskii, A.G. Synthesis and pharmacological activity of betulin dinicotinate. Russ. J. Bioorg. Chem., 2002, 28, 494-500.
42. Flekhter, O.B.; Nigmatullina, L.R.; Baltina, L.A.; Karachurina, L.T.; Galin, F.Z.; Zarudii, F.S.; Tolstikov, G.A.; Boreko, E.I.; Pavlova, N.I.; Nikolaeva, S.N.; Savinova, O.V. Synthesis of betulinic acid from betulin extract and study of the antiviral and antiulcer activity of some related terpenoids. Pharm. Chem. J., 2002, 36, 484-487.
43. Flekhter, O.B.; Ashavina, E.I.; Boreko, O.Y.; Karachurina, L.T.; Pavlova, N.I.; Kabalnova, N.N.; Savinova, O.V.; Galin, F.Z.; Nikolaeva, S.N.; Zarudii, F.S.; Baltina, L.A.; Tolstikov, G.A. Synthesis of 3-O-acetylbetulinic and betulonic aldehydes according to Svern and the pharmacological activity of related oximes. Pharm. Chem. J., 2002, 36, 303-306.
44. Flekhter, O.B.; Medvedeva, N.I.; Karachurina, L.T.; Baltina, L.A.; Zarudii, F.S.; Galin, F.Z.; Tolstikov, G.A. Synthesis and antiinflammatory activity of new acylated betulin derivatives. Pharm. Chem. J., 2002, 36, 488-491.
45. Flekhter, O.B.; Boreko, E.I.; Nigmatullina, L.R.; Tret’yakova, E.V.; Pavlova, N.I.; Baltina, L.A.; Nikolaeva, S.N.; Savinova, O.V.; Galin, F.Z.; Tolstikov, G.A. Synthesis and antiviral activity of ureides and carbamates of betulinic acid and its derivatives. Russ. J. Bioorg. Chem., 2003, 29, 594-600.
46. Baltina, L.A.; Flekhter, O.B.; Nigmatullina, L.R.; Boreko, E.I.; Pavlova, N.I.; Nikolaeve, S.N.; Savinova, O.V.; Tolstikov, G.A. Lupane triterpenes and derivatives with antiviral activity. Bioorg. Med. Chem. Lett., 2003, 13, 3549-3552.
47. Tung, N.H.; Kwon, H.J.; Kim, J.H.; Ra, J.C.; Kim, J.A.; Kim, Y.H. An anti-influenza component of the bark of Alnus japonica. Arch. Pharm. Res., 2010, 33, 363-367.
48. Kazakova, O.B.; Giniyatullina, G.V.; Yamansarov, E.Y.; Tolstikov, G.A. Betulin and ursolic acid synthetic derivatives as inhibitors of Papilloma virus. Bioorg. Med. Chem. Lett., 2010, 20, 4088-4090.
49. Ma, C.M.; Wu, X.H.; Masao, H.; Wang, X.J.; Kano, Y. HCV protease inhibitory, cytotoxic and apoptosis-inducing effects of oleanolic acid derivatives. J. Pharm. Pharm. Sci., 2009, 12, 243-248.
50. Yao, D.; Li, H.; Gou, Y.; Zhang, H.; Vlessidis, A.G.; Zhou, H.; Evmiridis, N.P.; Liu, Z. Betulinic acid-mediated inhibitory effect on hepatitis B virus by suppression of manganese superoxide dismutase expression. FEBS J., 2009, 276, 2599-2614.
51. Wen, C.C.; Kuo, Y.H.; Jan, J.T.; Liang, P.H.; Wang, S.Y.; Liu, H.G.; Lee, C.K.; Chang, S.T.; Kuo, C.J.; Lee, S.S.; Hou, C.C.; Hsiao, P.W.; Chien, S.C.; Shyur, L.F.; Yang, N.S. Specific plant terpenoids and lignoids possess potent antiviral activities against severe acute respiratory syndrome coronavirus. J. Med. Chem., 2007, 50, 4087-4095.
52. Chang, F.R.; Hsieh, Y.C.; Chang, Y.F.; Lee, K.H.; Wu, Y.C.; Chang, L.K. Inhibition of the Epstein-Barr virus lytic cycle by moronic acid. Antiviral Res., 2010, 85, 490-495.
53. Ryu, Y.B.; Park, S.J.; Kim, Y.M.; Lee, J.Y.; Seo, W.D.; Chang, J.S.; Park, K.H.; Rho, M.C.; Lee, W.S. SARS-CoV 3CLpro inhibitory effects of quinone-methide triterpenes from Tripterygium regelii. Bioorg. Med. Chem. Lett., 2010, 20, 1873-1876.
54. Narayan, V.; Ravindra, K.C.; Chiaro, C.; Cary, D.; Aggarwal, B.B.; Henderson, A.J.; Prabhu, K.S. Celastrol inhibits Tat-mediated human immunodeficiency virus (HIV) transcription and replication. J. Mol. Biol., 2011, 410, 972-983.
55. Pompei, R.; Flore, O.; Marccialis, M.A.; Pani, A.; Loddo, B. Glycyrrhizic acid inhibits virus growth and inactivates virus particles. Nature, 1979, 281, 689-690.
56. Baba, M.; Shigeta, S. Antiviral activity of glycyrrhizin against varicella-zoster virus in vitro. Antiviral Res., 1987, 7, 99-107.
57. Crance, J.M.; Scaramozzino, N.; Jouan, A.; Garin, D. Interferon, ribavirin, 6-azauridine and glycyrrhizin: antiviral compounds active against pathogenic flaviviruses. Antiviral Res., 2003, 58, 73-79.
58. Lin, J.C.; Cherng, J.M.; Hung, M.S.; Baltina, L.A.; Baltina, L.; Kondratenko, R. Inhibitory effects of some derivatives of glycyrrhizic acid against Epstein-Barr virus infection: structureactivity relationships. Antiviral Res., 2008, 79, 6-11.
59. Takahara, T.; Watanabe, A.; Shiraki, K. Effects of glycyrrhizin on hepatitis B surface antigen: a biochemical and morphological study. Hepatology, 1994, 21, 601-609.
60. Ito, M.; Nakashima, H.; Baba, M.; Pauwels, R.; De Clercq, E.; Shigeta, S.; Yamamoto N. Inhibitory effect of glycyrrhizin on the in vitro infectivity and cytopathic activity of the human immunodeficiency virus [HIV (HTLV-III/LAV)]. Antiviral Res., 1987, 7, 127-137.
61. Sasaki, H.; Takei, M.; Kobayashi, M.; Pollard, R.B.; Suzuki, F. Effect of glycyrrhizin, an active component of licorice roots, on HIV replication in cultures of peripheral blood mononuclear cells from HIV-seropositive patients. Pathobiology, 2002, 70, 229-236.
62. Cinat, J.: Morgenstern, B.; Bauer, G.; Chandra, P.; Rabenau, H. Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. Lancet, 2003, 361, 2045-2046.
63. Wolkerstorfer, A.; Kurz, H.; Bachhofner, N.; Szolar, O.H. Glycyrrhizin inhibits influenza A virus uptake into the cell. Antiviral Res., 2009, 83, 171-178.
64. Sui, X.; Yin, J.; Ren, X. Antiviral effect of diammonium glycyrrhizinate and lithium chloride on cell infection by pseudorabies herpesvirus. Antiviral Res., 2010, 85, 346-353.
65. Hardy, M.E.; Hendricks, J.M.; Paulson, J.M.; Faunce, N.R. 18betaglycyrrhetinic acid inhibits rotavirus replication in culture. Virol. J., 2012, 9, 96.
66. Kang, H.; Lieberman, P.M. Mechanism of glycyrrhizic acid inhibition of Kaposi's sarcoma-associated herpesvirus: disruption of CTCF-cohesin-mediated RNA polymerase II pausing and sister chromatid cohesion. J. Virol., 2011, 85, 11159-11169.
67. Ashfaq, U.A.; Masoud, M.S.; Nawaz, Z.; Riazuddin, S. Glycyrrhizin as antiviral agent against Hepatitis C Virus. J. Transl. Med., 2011, 9, 112-119.